tiany
Lv1
60 积分
2023-02-16 加入
-
Phase 1/2 Clinical Study of VRDN-001, A Full Antagonist Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R), in Patients with Thyroid Eye Disease (TED) (P3-9.001)
16天前
已关闭
-
干细胞治疗糖尿病:未来可期
1个月前
已完结
-
Progress and application of adipose-derived stem cells in the treatment of diabetes and its complications
1个月前
已完结
-
注射用奥马珠单抗生物类似药临床试验设计的审评考虑
1个月前
已完结
-
[Efficacy and safety of omalizumab in patients with refractory allergic asthma: a meta-analysis]
1个月前
已关闭
-
Novel erythropoiesis stimulating protein (NESP) effectively maintains hemoglobin (Hb) when administered at a reduced dose frequency compared with recombinant human erythropoietin (r-HuEPO) in ESRD patients
1个月前
已关闭
-
诱导痰联合呼出气一氧化氮、 鼻一氧 化氮检测在慢性咳嗽病因诊断中的应用研究
2个月前
已完结
-
FeNO、CaNO及支气管肺泡灌洗液细胞学分类在慢性咳嗽中的临床应用价值
2个月前
已完结
-
Orforglipron (LY3502970), a novel, oral non‐peptide glucagon‐like peptide‐1 receptor agonist: A Phase 1b, multicentre, blinded, placebo‐controlled, randomized, multiple‐ascending‐dose study in people with type 2 diabetes
3个月前
已关闭
-
Safety, pharmacokinetics and pharmacodynamics of HRS‐7535, a novel oral small molecule glucagon‐like peptide‐1 receptor agonist, in healthy participants: A phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose, and food effect trial
3个月前
已完结